Myeloma in the Real World: What Is Really Happening?

医学 临床试验 耐受性 重症监护医学 梅德林 内科学 不利影响 政治学 法学
作者
Krystal Bergin,Zoe McQuilten,Elizabeth Moore,Erica M. Wood,Andrew G Spencer
出处
期刊:Clinical Lymphoma, Myeloma & Leukemia [Elsevier BV]
卷期号:17 (3): 133-144.e1 被引量:42
标识
DOI:10.1016/j.clml.2016.12.002
摘要

Multiple myeloma (MM) is the second most common hematologic malignancy and is predominantly a disease of the elderly. In the past 2 decades, a range of new therapeutic options have become available, leading to improvements in patient outcomes, including both attainment of remission and overall survival. These improved outcomes have heralded a paradigm shift from a palliative approach toward more active management, including the use of sequential therapies, with the goal of prolonging progression-free and overall survival and preserving organ function to enable delivery of further therapy at relapse. Until now, most outcome data for MM have come from clinical trials, with few reports available on patients treated outside the clinical trial setting-in the "real world." Clinical trials are routinely undertaken in specialist centers, and extrapolation of these trial data to broader clinical practice might not accurately reflect "real-world" patient outcomes. Optimal management of MM is of key importance for positive patient outcomes, and further scrutiny of the efficacy and safety of the various reported therapies and how clinical trial findings are being translated or applied in the real-world management of MM is required. In the present review, we have described the minimal published evidence available through a comprehensive published data search of MEDLINE using the OvidSP interface on the management and outcomes of MM outside the setting of clinical trials, including evidence on the uptake of new therapies and their efficacy and tolerability in standard practice. Clinical registries might be able to help provide these data in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
蟹老板发布了新的文献求助10
1秒前
1秒前
wyt完成签到,获得积分10
1秒前
2秒前
陈鹿华完成签到 ,获得积分10
2秒前
wlin发布了新的文献求助10
2秒前
lili发布了新的文献求助10
2秒前
花样年华发布了新的文献求助150
2秒前
大模型的应助被Zheng采纳,获得10
2秒前
何曼慈发布了新的文献求助10
3秒前
隐形曼青的应助被Lily采纳,获得10
3秒前
cain完成签到 ,获得积分10
4秒前
4秒前
shi发布了新的文献求助10
4秒前
4秒前
Mimo发布了新的文献求助10
5秒前
苏小咩发布了新的文献求助10
6秒前
雪白冷荷完成签到,获得积分10
6秒前
JPH1990发布了新的文献求助10
7秒前
gao完成签到,获得积分10
7秒前
Deb完成签到,获得积分20
7秒前
大模型的应助被忧郁醉薇采纳,获得10
8秒前
8秒前
Light完成签到,获得积分10
9秒前
wjsbhsn发布了新的文献求助10
9秒前
李李发布了新的文献求助10
9秒前
9秒前
10秒前
合适怜南完成签到,获得积分10
10秒前
香蕉觅云的应助被tangyan采纳,获得10
10秒前
11秒前
CodeCraft的应助被ZYH采纳,获得10
11秒前
啦啦完成签到,获得积分10
11秒前
哦呦看灰机完成签到,获得积分10
11秒前
完美世界的应助被SPINE采纳,获得10
12秒前
忧伤的乌完成签到 ,获得积分10
12秒前
哭泣微笑的应助被嘻嘻哈哈采纳,获得210
12秒前
晨曦完成签到,获得积分10
12秒前
赘婿的应助被葡小小采纳,获得10
13秒前
打打的应助被stone采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148